Moreover, unlike other dystroglycanopathies, patient fibroblasts exhibit normal α‐dystroglycan glycosylation and laminin binding. This evidence concerns the gene LAMB2 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.